| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Goodman Jesse is a Director at NTLA. Recent filings cover 0 purchases and 2 sales. Those positions are worth an estimated $293K at current prices.
Goodman Jesse's largest disclosed position is in NTLA as Director, worth about $293K. The recent filings there lean toward selling, a net 3,094 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | NTLA Intellia Therapeutics, Inc. | Director | Sell | 3,094 | $9.40 | $29,068.13 | -5.8% | +71.3% | +74.5% |